Xtant Medical Holdings XTNT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $20.88M-36.5% | $32.36M+2.7% | $33.26M+19.0% | $35.41M+18.3% | $32.9M+18.0% | ||
| $8.91M-29.6% | $14.6M-5.7% | $11.26M-3.2% | $11.13M-2.1% | $12.66M+19.8% | ||
| $11.97M-40.9% | $17.75M+10.8% | $21.99M+34.9% | $24.28M+30.7% | $20.24M+17.0% | ||
| 57.3%-4.2pp | 54.9%+4.0pp | 66.1%+7.8pp | 68.6%+6.5pp | 61.5%-0.6pp | ||
| $435K-1.8% | $459K-12.1% | $634K-9.6% | $566K-11.0% | $443K-15.9% | ||
| $8.19M-26.9% | $10.95M-6.3% | $11.75M-1.2% | $11.62M-11.9% | $11.2M-10.1% | ||
| $6.27M-16.7% | $7.29M+27.9% | $7.07M-5.6% | $7.48M-3.0% | $7.53M-3.2% | ||
| $534K-50.3% | $1.82M+58.4% | $1.16M+8.2% | $1.17M+17.1% | $1.07M+6.9% | ||
| $14.89M-22.3% | $18.7M+4.4% | $19.45M-3.2% | $19.66M-8.7% | $19.18M-7.7% | ||
| -$2.92M-375% | —— | $2.54M+167% | $4.62M+257% | $1.06M+131% | ||
| -14%-17.2pp | —— | 7.6%+21.2pp | 13.1%+22.9pp | 3.2%+15.7pp | ||
| $599K-42.7% | $718K-36.7% | $904K-24.6% | $1M+1.2% | $1.05M+25.1% | ||
| $219K+832% | $23.5K— | $23.5K— | $23.5K— | $23.5K— | ||
| -$139K+86.5% | —— | -$976K+17.6% | -$819K+6.8% | -$1.03M-19.5% | ||
| -$3.06M-9,379% | $1.6M+151% | $1.57M+132% | $3.81M+199% | $33K+101% | ||
| $27K+208% | $1.54M+7,238% | $257K+315% | $255K+608% | -$25K-137% | ||
| -$3.09M-5,426% | $57K+102% | $1.31M+126% | $3.55M+192% | $58K+101% | ||
| -14.8%-15.0pp | 0.2%+10.2pp | 3.9%+21.9pp | 10%+22.9pp | 0.2%+16.0pp | ||
| -$0.02— | $0.00+100% | $0.01+125% | $0.02+167% | $0.00+100% | ||
| -$0.02— | $0.00+100% | $0.01+125% | $0.03+200% | $0.00+100% | ||
| 140.1M-2.3% | 150M+12.3% | 150.4M+11.3% | 148.6M+14.1% | 143.3M+10.1% | ||
| 140.1M+0.7% | 139.5M+4.4% | 139.7M+3.4% | 139.3M+6.9% | 139.1M+6.8% | ||
| -$1K-104% | -$206K— | -$56K-307% | $178K+50.8% | $24K+162% | ||
| —— | $820.25K— | $820.25K— | $820.25K— | $820.25K— | ||
| $242K+2,789% | $91K+437% | -$16K-23.1% | $7K+240% | -$9K-175% | ||
| $20.88M-36.5% | $32.36M+2.7% | $33.26M+19.0% | $35.41M+18.3% | $32.9M+18.0% | ||
| -$2.92M-375% | $2.32M+223% | $2.54M+167% | $4.62M+257% | $1.06M+131% | ||
| -$2.39M-212% | $4.14M+663% | $3.7M+237% | $5.79M+397% | $2.14M+187% | ||
| -$2.39M-212% | $4.14M+663% | $3.7M+237% | $5.79M+397% | $2.14M+187% | ||
| -11.4%-17.9pp | 12.8%+15.1pp | 11.1%+20.8pp | 16.4%+22.9pp | 6.5%+15.3pp | ||
| -$2.92M-375% | $2.32M+223% | $2.54M+167% | $4.62M+257% | $1.06M+131% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Xtant Medical Holdings's revenue?
- Xtant Medical Holdings (XTNT) generated $121.9M in revenue over the trailing twelve months, down 0.3% year over year.
- Is Xtant Medical Holdings profitable?
- Xtant Medical Holdings reported $1.8M in net income over the trailing twelve months, a 1.5% net margin.
- What are Xtant Medical Holdings's profit margins?
- Gross margin is 62.3% and operating margin is 4.8%, with a 1.5% net margin.
- What is Xtant Medical Holdings's earnings per share?
- Xtant Medical Holdings's diluted EPS over the trailing twelve months is $0.01.
- Where does Xtant Medical Holdings's income statement data come from?
- Every line is extracted from Xtant Medical Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
